InvestorsHub Logo

mjt

Followers 2
Posts 210
Boards Moderated 0
Alias Born 08/22/2016

mjt

Re: Longmoney post# 5014

Friday, 01/12/2018 1:14:08 PM

Friday, January 12, 2018 1:14:08 PM

Post# of 7901
Again, this is what Senhance has that DaVinci doesn't:

-open architecture
-interfaces with current hospitals devices
-haptic feedback
-eye sensing camera control
-comfortable ergonomics
-reusable trocars
-easy instrument exchange
-significantly less expensive device
-mimics current laparoscopy making it easy to learn
-3mm instruments already being utilized in EU, making virtually scarless
surgery!

FDA approval only 3 mos ago, and there is a 4-6 quarter sales cycle. You cannot even try to sell a product before it's approved it is against the law! TRXC is on the right track.

You cannot compare a company's sales that has had a monopoly for 17 years of sales to a company's sales, that has only had an FDA approval for 3 months!